TIPZ:NYE-PIMCO Broad U.S. TIPS Index Exchange-Traded Fund (USD)

ETF | Inflation-Protected Bond |

Last Closing

USD 53.495

Change

-0.39 (-0.73)%

Market Cap

N/A

Volume

5.41K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Inflation-Protected Bond

Symbol Name Price(Change) Market Cap
SCHP Schwab U.S. TIPS ETF

-0.38 (-0.71%)

USD 11.61B
STIP iShares 0-5 Year TIPS Bond ETF

-0.36 (-0.36%)

USD 7.76B
TDTT FlexShares iBoxx 3-Year Target..

-0.13 (-0.54%)

USD 1.76B
TIPX SPDR® Bloomberg 1-10 Year TIP..

-0.12 (-0.63%)

USD 1.41B
TDTF FlexShares iBoxx 5-Year Target..

-0.16 (-0.67%)

USD 0.69B
STPZ PIMCO 1-5 Year U.S. TIPS Index..

-0.25 (-0.47%)

USD 0.48B
LTPZ PIMCO 15+ Year U.S. TIPS Index..

-0.58 (-1.01%)

N/A
TIP iShares TIPS Bond ETF

-0.75 (-0.68%)

N/A

ETFs Containing TIPZ

SNUG 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Inflation-Protected Bond) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.32% 22% F 26% F
Dividend Return 3.53% 100% F 61% D-
Total Return 3.85% 22% F 28% F
Trailing 12 Months  
Capital Gain 5.18% 44% F 25% F
Dividend Return 4.80% 100% F 61% D-
Total Return 9.98% 78% C+ 27% F
Trailing 5 Years  
Capital Gain -11.45% 22% F 30% F
Dividend Return 16.73% 78% C+ 58% F
Total Return 5.28% 22% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain -3.59% N/A N/A 21% F
Dividend Return -0.23% N/A N/A 23% F
Total Return 3.37% N/A N/A 64% D
Risk Return Profile  
Volatility (Standard Deviation) 6.82% N/A N/A 86% B+
Risk Adjusted Return -3.35% N/A N/A 22% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike